
We aim to push the frontiers of genetic medicine by building precise and scalable technologies that unlock transformative therapies and redefine the future of human health.
We are developing a next-generation platform for precision genetic medicine, designed to overcome the limitations of traditional gene editing and expand the scope of genomic therapeutics.
Our approach focuses on achieving highly targeted, efficient, and safe genetic modifications across a wide range of applications, from ex vivo cell engineering to in vivo therapeutic delivery.
Our platform integrates a suite of advanced and clinically validated delivery technologies to enable effective genetic engineering across diverse biological systems.
These include:
Together, these technologies form a flexible and scalable delivery engine supporting a broad range of therapeutic strategies.
Our technologies are designed to support a wide spectrum of therapeutic areas, including:
We focus on translating scientific innovation into real-world clinical impact.
We are building a robust pipeline of genetic medicine programs targeting diseases with high unmet clinical needs.
Our portfolio spans from early-stage discovery to preclinical development, with a focus on advancing differentiated and potentially first-in-class therapeutic candidates.
Innovation is at the core of our platform.
We integrate cutting-edge biology, computational approaches, and data-driven insights to accelerate discovery, optimize design, and continuously enhance the performance of our genetic technologies.